 | | A1CMD | | Name: | (2P)-2-[2-(ethylamino)-1,3-benzothiazol-6-yl]cyclopent-1-ene-1-carboxylic acid | | Formula: | C15 H16 N2 O2 S | | SMILES: | O=C(O)C=1CCCC=1c1ccc2nc(NCC)sc2c1 | | InChi: | InChI=1S/C15H16N2O2S/c1-2-16-15-17-12-7-6-9(8-13(12)20-15)10-4-3-5-11(10)14(18)19/h6-8H,2-5H2,1H3,(H,16,17)(H,18,19) | | Definition date: | 2025-08-05 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | (2P)-2-[2-(ethylamino)-1,3-benzothiazol-6-yl]cyclopent-1-ene-1-carboxylic acid |
|
 | | A1CME | | Name: | (2P)-2-(quinolin-7-yl)cyclopent-1-ene-1-carboxylic acid | | Formula: | C15 H13 N O2 | | SMILES: | O=C(O)C=1CCCC=1c1cc2ncccc2cc1 | | InChi: | InChI=1S/C15H13NO2/c17-15(18)13-5-1-4-12(13)11-7-6-10-3-2-8-16-14(10)9-11/h2-3,6-9H,1,4-5H2,(H,17,18) | | Definition date: | 2025-08-05 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | (2P)-2-(quinolin-7-yl)cyclopent-1-ene-1-carboxylic acid |
|
 | | A1I5Z | | Name: | 6-azanyl-1-[2-(azetidin-3-yl)ethyl]-2-cycloheptyl-4-ethoxy-pyrazolo[3,4-d]pyrimidin-3-one | | Formula: | C19 H30 N6 O2 | | SMILES: | CCOc1nc(N)nc2N(CCC3CNC3)N(C4CCCCCC4)C(=O)c12 | | InChi: | InChI=1S/C19H30N6O2/c1-2-27-17-15-16(22-19(20)23-17)24(10-9-13-11-21-12-13)25(18(15)26)14-7-5-3-4-6-8-14/h13-14,21H,2-12H2,1H3,(H2,20,22,23) | | Definition date: | 2025-03-12 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | 6-azanyl-1-[2-(azetidin-3-yl)ethyl]-2-cycloheptyl-4-ethoxy-pyrazolo[3,4-d]pyrimidin-3-one |
|
 | | A1I62 | | Name: | 2-azanyl-4-ethoxy-6-[(1~{R},2~{S})-2-oxidanylcyclohexyl]-7~{H}-pyrrolo[3,4-d]pyrimidin-5-one | | Formula: | C14 H20 N4 O3 | | SMILES: | CCOc1nc(N)nc2CN([CH]3CCCC[CH]3O)C(=O)c12 | | InChi: | InChI=1S/C14H20N4O3/c1-2-21-12-11-8(16-14(15)17-12)7-18(13(11)20)9-5-3-4-6-10(9)19/h9-10,19H,2-7H2,1H3,(H2,15,16,17)/t9-,10+/m1/s1 | | Definition date: | 2025-03-19 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | 2-azanyl-4-ethoxy-6-[(1~{R},2~{S})-2-oxidanylcyclohexyl]-7~{H}-pyrrolo[3,4-d]pyrimidin-5-one |
|
 | | A1IKF | | Name: | N-(2-(2-(2-acetamidoethoxy)ethoxy)ethyl)-3-(N-(1,3-dimethyl-2-oxo-6-(3-propoxyphenoxy)-2,3-dihydro-1H-benzo[d]imidazol-5-yl)sulfamoyl)benzamide | | Formula: | C33 H41 N5 O9 S | | SMILES: | CCCOc1cccc(Oc2cc3N(C)C(=O)N(C)c3cc2N[S](=O)(=O)c4cccc(c4)C(=O)NCCOCCOCCNC(C)=O)c1 | | InChi: | InChI=1S/C33H41N5O9S/c1-5-14-46-25-9-7-10-26(20-25)47-31-22-30-29(37(3)33(41)38(30)4)21-28(31)36-48(42,43)27-11-6-8-24(19-27)32(40)35-13-16-45-18-17-44-15-12-34-23(2)39/h6-11,19-22,36H,5,12-18H2,1-4H3,(H,34,39)(H,35,40) | | Definition date: | 2024-08-07 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | ~{N}-[2-[2-(2-acetamidoethoxy)ethoxy]ethyl]-3-[[1,3-dimethyl-2-oxidanylidene-6-(3-propoxyphenoxy)benzimidazol-5-yl]sulfamoyl]benzamide |
|
 | | A1IOS | | Name: | stanozolol | | Formula: | C21 H32 N2 O | | SMILES: | C[C]1(O)CC[CH]2[CH]3CC[CH]4Cc5n[nH]cc5C[C]4(C)[CH]3CC[C]12C | | InChi: | InChI=1S/C21H32N2O/c1-19-11-13-12-22-23-18(13)10-14(19)4-5-15-16(19)6-8-20(2)17(15)7-9-21(20,3)24/h12,14-17,24H,4-11H2,1-3H3,(H,22,23)/t14-,15+,16-,17-,19-,20-,21-/m0/s1 | | Definition date: | 2024-09-16 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 |
|
 | | A1IXE | | Name: | 1-(2,8-dioxa-5-azaspiro[3.6]decan-5-yl)-2-[[5-methyl-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]ethanone | | Formula: | C19 H24 N4 O3 S | | SMILES: | Cc1ccc(cc1)n2c(C)nnc2SCC(=O)N3CCOCCC34COC4 | | InChi: | InChI=1S/C19H24N4O3S/c1-14-3-5-16(6-4-14)23-15(2)20-21-18(23)27-11-17(24)22-8-10-25-9-7-19(22)12-26-13-19/h3-6H,7-13H2,1-2H3 | | Definition date: | 2024-12-19 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | 1-(2,8-dioxa-5-azaspiro[3.6]decan-5-yl)-2-[[5-methyl-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]ethanone |
|
 | | A1IXF | | Name: | methyl 2,2,6,6-tetramethyl-4-[[2-[(5-methyl-1,3,4-thiadiazol-2-yl)amino]-2-oxidanylidene-ethyl]amino]oxane-4-carboxylate | | Formula: | C16 H26 N4 O4 S | | SMILES: | COC(=O)C1(CC(C)(C)OC(C)(C)C1)NCC(=O)Nc2sc(C)nn2 | | InChi: | InChI=1S/C16H26N4O4S/c1-10-19-20-13(25-10)18-11(21)7-17-16(12(22)23-6)8-14(2,3)24-15(4,5)9-16/h17H,7-9H2,1-6H3,(H,18,20,21) | | Definition date: | 2024-12-19 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | methyl 2,2,6,6-tetramethyl-4-[[2-[(5-methyl-1,3,4-thiadiazol-2-yl)amino]-2-oxidanylidene-ethyl]amino]oxane-4-carboxylate |
|
 | | A1JAT | | Name: | (6R,6aR,7S,10R,10aS)-6-(3,5-bis(trifluoromethyl)phenyl)-5,6,6a,7,8,9,10,10a-octahydro-7,10-methanophenanthridine-3-carboxylic acid | | Formula: | C23 H19 F6 N O2 | | SMILES: | OC(=O)c1ccc2[CH]3[CH]4CC[CH](C4)[CH]3[CH](Nc2c1)c5cc(cc(c5)C(F)(F)F)C(F)(F)F | | InChi: | InChI=1S/C23H19F6NO2/c24-22(25,26)14-6-13(7-15(9-14)23(27,28)29)20-19-11-2-1-10(5-11)18(19)16-4-3-12(21(31)32)8-17(16)30-20/h3-4,6-11,18-20,30H,1-2,5H2,(H,31,32)/t10-,11+,18-,19-,20+/m1/s1 | | Definition date: | 2025-04-10 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 |
|
 | | A1JB2 | | Name: | 4-[4-[[7-(dimethylamino)-2,1,3-benzoxadiazol-4-yl]sulfonyl]piperazin-1-yl]sulfonyl-5-pyridin-3-yl-benzene-1,2-diol | | Formula: | C23 H24 N6 O7 S2 | | SMILES: | CN(C)c1ccc(c2nonc12)[S](=O)(=O)N3CCN(CC3)[S](=O)(=O)c4cc(O)c(O)cc4c5cccnc5 | | InChi: | InChI=1S/C23H24N6O7S2/c1-27(2)17-5-6-20(23-22(17)25-36-26-23)37(32,33)28-8-10-29(11-9-28)38(34,35)21-13-19(31)18(30)12-16(21)15-4-3-7-24-14-15/h3-7,12-14,30-31H,8-11H2,1-2H3 | | Synonyms: | DEHSUWFLXFTDPH-UHFFFAOYSA-N | | Definition date: | 2025-05-07 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | 4-[4-[[7-(dimethylamino)-2,1,3-benzoxadiazol-4-yl]sulfonyl]piperazin-1-yl]sulfonyl-5-pyridin-3-yl-benzene-1,2-diol |
|
 | | A1JB3 | | Name: | 4-[4-[(7-azanyl-2,1,3-benzoxadiazol-4-yl)sulfonyl]piperazin-1-yl]sulfonylbenzene-1,2-diol | | Formula: | C16 H17 N5 O7 S2 | | SMILES: | Nc1ccc(c2nonc12)[S](=O)(=O)N3CCN(CC3)[S](=O)(=O)c4ccc(O)c(O)c4 | | InChi: | InChI=1S/C16H17N5O7S2/c17-11-2-4-14(16-15(11)18-28-19-16)30(26,27)21-7-5-20(6-8-21)29(24,25)10-1-3-12(22)13(23)9-10/h1-4,9,22-23H,5-8,17H2 | | Synonyms: | BEHXKSOMSFVUBW-UHFFFAOYSA-N | | Definition date: | 2025-05-07 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | 4-[4-[(7-azanyl-2,1,3-benzoxadiazol-4-yl)sulfonyl]piperazin-1-yl]sulfonylbenzene-1,2-diol |
|
 | | A1JBW | | Name: | 4-[4-[[7-(dimethylamino)-2,1,3-benzoxadiazol-4-yl]sulfonyl]piperazin-1-yl]sulfonylbenzene-1,2-diol | | Formula: | C18 H21 N5 O7 S2 | | SMILES: | CN(C)c1ccc(c2nonc12)[S](=O)(=O)N3CCN(CC3)[S](=O)(=O)c4ccc(O)c(O)c4 | | InChi: | InChI=1S/C18H21N5O7S2/c1-21(2)13-4-6-16(18-17(13)19-30-20-18)32(28,29)23-9-7-22(8-10-23)31(26,27)12-3-5-14(24)15(25)11-12/h3-6,11,24-25H,7-10H2,1-2H3 | | Definition date: | 2025-05-07 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | 4-[4-[[7-(dimethylamino)-2,1,3-benzoxadiazol-4-yl]sulfonyl]piperazin-1-yl]sulfonylbenzene-1,2-diol |
|
 | | A1JBZ | | Name: | 4-[4-[(7-piperidin-1-yl-2,1,3-benzoxadiazol-4-yl)sulfonyl]piperazin-1-yl]sulfonylbenzene-1,2-diol | | Formula: | C21 H25 N5 O7 S2 | | SMILES: | Oc1ccc(cc1O)[S](=O)(=O)N2CCN(CC2)[S](=O)(=O)c3ccc(N4CCCCC4)c5nonc35 | | InChi: | InChI=1S/C21H25N5O7S2/c27-17-6-4-15(14-18(17)28)34(29,30)25-10-12-26(13-11-25)35(31,32)19-7-5-16(20-21(19)23-33-22-20)24-8-2-1-3-9-24/h4-7,14,27-28H,1-3,8-13H2 | | Synonyms: | ISODZKPLYYJZLI-UHFFFAOYSA-N | | Definition date: | 2025-05-07 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | 4-[4-[(7-piperidin-1-yl-2,1,3-benzoxadiazol-4-yl)sulfonyl]piperazin-1-yl]sulfonylbenzene-1,2-diol |
|
 | | A1JC6 | | Name: | (~{E})-3-[3-[oxidanyl(oxidanylidene)-$l^{4}-azanyl]phenyl]-1-[3-(trifluoromethyl)phenyl]prop-2-en-1-one | | Formula: | C16 H10 F3 N O3 | | SMILES: | FC(F)(F)c1cccc(c1)C(=O)C=Cc2cccc(c2)[N+](=O)=O | | InChi: | InChI=1S/C16H10F3NO3/c17-16(18,19)13-5-2-4-12(10-13)15(21)8-7-11-3-1-6-14(9-11)20(22)23/h1-10H/q+1/b8-7+ | | Definition date: | 2025-05-12 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | (~{E})-3-[3-[oxidanyl(oxidanylidene)-$l^{4}-azanyl]phenyl]-1-[3-(trifluoromethyl)phenyl]prop-2-en-1-one |
|
 | | A1JC8 | | Name: | (~{E})-3-(1,3-benzodioxol-5-yl)-1-[3-(trifluoromethyl)phenyl]prop-2-en-1-one | | Formula: | C17 H11 F3 O3 | | SMILES: | FC(F)(F)c1cccc(c1)C(=O)C=Cc2ccc3[oH]coc3c2 | | InChi: | InChI=1S/C17H11F3O3/c18-17(19,20)13-3-1-2-12(9-13)14(21)6-4-11-5-7-15-16(8-11)23-10-22-15/h1-10,22H/b6-4+ | | Definition date: | 2025-05-12 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | (~{E})-3-(1,3-benzodioxol-5-yl)-1-[3-(trifluoromethyl)phenyl]prop-2-en-1-one |
|
 | | A1JFD | | Name: | 2-[(4~{S})-1,1,6,6-tetrakis(oxidanyl)-3-oxidanylidene-2,5$l^{3},7-trioxa-1$l^{5},6$l^{4}-divanadabicyclo[3.2.0]heptan-4-yl]ethanoic acid | | Formula: | C4 H8 O10 V2 | | SMILES: | OC(=O)C[CH]1[O+]2[V](O)(O)O[V]2(O)(O)OC1=O | | InChi: | InChI=1S/C4H5O5.4H2O.O.2V/c5-2(4(8)9)1-3(6)7 | | Synonyms: | dioxovanadium(V) complex of malic acid | | Definition date: | 2025-06-04 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | 2-[(4~{S})-1,1,6,6-tetrakis(oxidanyl)-3-oxidanylidene-2,7-dioxa-5-oxonia-1$l^{5},6$l^{4}-divanadabicyclo[3.2.0]heptan-4-yl]ethanoic acid |
|
 | | A1JHO | | Name: | 6S,6aS,7R,10S,10aR)-6-(3,5-bis(trifluoromethyl)phenyl)-5,6,6a,7,8,9,10,10a-octahydro-7,10-methanophenanthridine-3-carboxylic acid | | Formula: | C23 H19 F6 N O2 | | SMILES: | OC(=O)c1ccc2[CH]3[CH]4CC[CH](C4)[CH]3[CH](Nc2c1)c5cc(cc(c5)C(F)(F)F)C(F)(F)F | | InChi: | InChI=1S/C23H19F6NO2/c24-22(25,26)14-6-13(7-15(9-14)23(27,28)29)20-19-11-2-1-10(5-11)18(19)16-4-3-12(21(31)32)8-17(16)30-20/h3-4,6-11,18-20,30H,1-2,5H2,(H,31,32)/t10-,11+,18-,19-,20+/m0/s1 | | Definition date: | 2025-06-18 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 |
|
 | | A1JHR | | Name: | Gly-Ser-epsilon-Lys | | Formula: | C11 H22 N4 O5 | | SMILES: | NCC(=O)N[CH](CO)C(=O)NCCCC[CH](N)C(O)=O | | InChi: | InChI=1S/C11H22N4O5/c12-5-9(17)15-8(6-16)10(18)14-4-2-1-3-7(13)11(19)20/h7-8,16H,1-6,12-13H2,(H,14,18)(H,15,17)(H,19,20)/t7-,8-/m0/s1 | | Synonyms: | (2S)-2-azanyl-6-[[(2S)-2-(2-azanylethanoylamino)-3-oxidanyl-propanoyl]amino]hexanoic acid | | Definition date: | 2025-06-19 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | (2~{S})-2-azanyl-6-[[(2~{S})-2-(2-azanylethanoylamino)-3-oxidanyl-propanoyl]amino]hexanoic acid |
|
 | | A1JLP | | Name: | 1-(3,5-dihydro-2~{H}-1,4-benzothiazepin-4-yl)ethanone | | Formula: | C11 H13 N O S | | SMILES: | CC(=O)N1CCSc2ccccc2C1 | | InChi: | InChI=1S/C11H13NOS/c1-9(13)12-6-7-14-11-5-3-2-4-10(11)8-12/h2-5H,6-8H2,1H3 | | Definition date: | 2025-07-29 | | Last modified: | 2025-08-08 | | Release date: | 2025-08-13 | | Identifier: | 1-(3,5-dihydro-2~{H}-1,4-benzothiazepin-4-yl)ethanone |
|
 | | FME | | Name: | N-FORMYLMETHIONINE | | Formula: | C6 H11 N O3 S | | SMILES: | O=CNC(C(=O)O)CCSC | | InChi: | InChI=1S/C6H11NO3S/c1-11-3-2-5(6(9)10)7-4-8/h4-5H,2-3H2,1H3,(H,7,8)(H,9,10)/t5-/m0/s1 | | Definition date: | 1999-07-08 | | Last modified: | 2025-08-04 | | Identifier: | N-formyl-L-methionine |
|
 | | 8G2 | | Name: | (4-methoxycarbonylphenyl)methylazanium | | Formula: | C9 H12 N O2 | | SMILES: | COC(=O)c1ccc(C[NH3+])cc1 | | InChi: | InChI=1S/C9H11NO2/c1-12-9(11)8-4-2-7(6-10)3-5-8/h2-5H,6,10H2,1H3/p+1 | | Definition date: | 2017-02-06 | | Last modified: | 2025-08-01 | | Release date: | 2018-02-28 | | Identifier: | (4-methoxycarbonylphenyl)methylazanium |
|
 | | A1AVA | | Name: | 2-acetamido-2,3-dideoxy-D-ribo-hexitol | | Formula: | C8 H17 N O5 | | SMILES: | OC(CC(NC(C)=O)CO)C(O)CO | | InChi: | InChI=1S/C8H17NO5/c1-5(12)9-6(3-10)2-7(13)8(14)4-11/h6-8,10-11,13-14H,2-4H2,1H3,(H,9,12)/t6-,7+,8-/m1/s1 | | Definition date: | 2024-06-14 | | Last modified: | 2025-08-01 | | Release date: | 2025-08-06 | | Identifier: | 2-acetamido-2,3-dideoxy-D-ribo-hexitol |
|
 | | C2A | | Name: | 1-(3-CHLOROPHENYL)METHANAMINE | | Formula: | C7 H8 Cl N | | SMILES: | Clc1cc(ccc1)CN | | InChi: | InChI=1S/C7H8ClN/c8-7-3-1-2-6(4-7)5-9/h1-4H,5,9H2 | | Synonyms: | INHIBITOR OF THROMBIN | | Definition date: | 2005-12-08 | | Last modified: | 2025-08-01 | | Identifier: | 1-(3-chlorophenyl)methanamine |
|
 | | A1BUJ | | Name: | (6R,12R)-6-(5-bromofuran-2-yl)-7,9-dimethyl-8,10-dioxo-11-phenyl-7,8,9,10-tetrahydro-6H-pyrimido[4',5':3,4]pyrrolo[2,1-c][1,4]benzoxazine-2-carboxylic acid | | Formula: | C26 H18 Br N3 O6 | | SMILES: | Brc1ccc(o1)C1Oc2ccc(cc2n2c(c3ccccc3)c3C(=O)N(C)C(=O)N(C)c3c12)C(=O)O | | InChi: | InChI=1S/C26H18BrN3O6/c1-28-21-19(24(31)29(2)26(28)34)20(13-6-4-3-5-7-13)30-15-12-14(25(32)33)8-9-16(15)36-23(22(21)30)17-10-11-18(27)35-17/h3-12,23H,1-2H3,(H,32,33)/t23-/m0/s1 | | Definition date: | 2025-01-24 | | Last modified: | 2025-08-01 | | Release date: | 2025-08-06 | | Identifier: | (6R,12R)-6-(5-bromofuran-2-yl)-7,9-dimethyl-8,10-dioxo-11-phenyl-7,8,9,10-tetrahydro-6H-pyrimido[4',5':3,4]pyrrolo[2,1-c][1,4]benzoxazine-2-carboxylic acid |
|
 | | A1CEF | | Name: | 5-(4-{[(2R)-6,6-dimethyl-1,4-dioxan-2-yl]methoxy}phenyl)-2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxamide | | Formula: | C20 H21 F3 N2 O5 | | SMILES: | NC(=O)C1=CC(=C(NC1=O)C(F)(F)F)c1ccc(OCC2COCC(C)(C)O2)cc1 | | InChi: | InChI=1S/C20H21F3N2O5/c1-19(2)10-28-8-13(30-19)9-29-12-5-3-11(4-6-12)14-7-15(17(24)26)18(27)25-16(14)20(21,22)23/h3-7,13H,8-10H2,1-2H3,(H2,24,26)(H,25,27) | | Definition date: | 2025-05-28 | | Last modified: | 2025-08-01 | | Release date: | 2025-08-06 | | Identifier: | 5-(4-{[(2R)-6,6-dimethyl-1,4-dioxan-2-yl]methoxy}phenyl)-2-oxo-6-(trifluoromethyl)-1,2-dihydropyridine-3-carboxamide |
|